Wordt geladen...
DESIGNING PHASE II B TRIALS IN SARCOPENIA THE BEST TARGET POPULATION
Despite the existing limitations and controversies regarding the definition of sarcopenia and its clinical consequences, the current scientific evidence strongly suggests that muscle decline is a primary determinant of the disabling process (and likely of other major health-related events). In fact,...
Bewaard in:
| Gepubliceerd in: | J Nutr Health Aging |
|---|---|
| Hoofdauteurs: | , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
2011
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4311892/ https://ncbi.nlm.nih.gov/pubmed/21968872 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|